Eli Lilly said it is investing another $5.3 billion in a manufacturing plant in Lebanon, Indiana, to expand the supply of its highly popular weight loss drug Zepbound, diabetes treatment Mounjaro ...
New investment brings Lilly’s total commitment at LEAP Research and Innovation District in Lebanon to $9 billion, 900 new jobs. In addition to the new investment, Lilly will create another ...
Eli Lilly plans to invest an additional $5.3B to manufacture more of its blockbuster weight-loss and diabetes treatments at its Indiana plant, the pharma giant announced Friday. The expansion is ...
Since scoring approval two years ago for its next-generation diabetes treatment Mounjaro (tirzepatide), Eli Lilly has been playing catch up with market leader Novo Nordisk. On Friday, the ...
Faced with overwhelming demand for its diabetes treatment Mounjaro and weight-loss treatment Zepbound, Indianapolis-based drugmaker Eli Lilly and Co. said Friday morning it plans to invest another ...
Eli Lilly will spend more than $5 billion to expand an Indiana manufacturing site and eventually make more doses of its hot-selling weight-loss and diabetes treatments, Zepbound and Mounjaro Eli ...
Eli Lilly and Co., is more than doubling its investment in its Boone County manufacturing site to increase production of ingredients in its blockbuster weight loss and diabetes drugs. The ...
Eli Lilly will invest an additional $5.3 billion into a new manufacturing site, boosting production for its weight loss and diabetes medications Mounjaro and Zepbound, the pharmaceutical firm said ...
Governor Roy Coope, Eli Lilly officials and others were on hand as the new $2 billion facility opened on Concord Friday, June ...
North Carolina Governor Roy Cooper is in Concord Friday for the ribbon-cutting ceremony of pharmaceutical company Eli Lilly’s ...
The expansion will enhance Lilly's capacity to manufacture tirzepatide, an active pharmaceutical ingredient for Zepbound and Mounjaro. Eli Lilly expects to begin making medicines in Lebanon ...